• 제목/요약/키워드: lipid tolerance test

검색결과 73건 처리시간 0.02초

Guar gum이 type-II 당뇨병 환자의 혈액성분에 미치는 영향 (Effect of guar gum on the blood composition in type-II diabetic subjects)

  • 김은미
    • Journal of Nutrition and Health
    • /
    • 제22권6호
    • /
    • pp.457-465
    • /
    • 1989
  • Guar gum, a storage polysaccharide galactomannan was administered to 11 patients with type-II diabetes mellitus for 7 days and 3 weeks. They took 5 grams of guar gum 30 mins before each of three meals daily. The dinner 2-h postprandial values of their blood glucose were significantly lowered (P<0.05) after their guar treatment for 7 days compared with before taking guar gum. The 2-h postprandial values of blood glucose were significantly lowered(P<0.05) after 3 weeks of gual treatment compared with before taking guar gum. In an oral glucose tolerance test, their blood glucose values were significantly lowered at 120 mins(P<0.02) and 180 mins(P<0.05) after guar treatment. Total-lipid(P<0.01) and triglycerides(P<0.02) of their blood were significantly decreased and HDL-cholesterol(P<0.02) was significantly increased after guar treatment. HbA1C was significantly reduced (P<0.05) from 11.3% to 10.1% The body weight, total-cholesterol and insulin activity of the patients after guar treatment were not significantly changed and the satiety ratings of the patients with guar treatment was not significantly changed and the satiety ratings of the patients with guar treatment was not significantly changed, however, the subjects that answered from 'Want to eat but can wait' to 'No desire to eat' were 81.1%. It is concluded that guar gum improves their carbohydrate and lipid metabolism in Korean type-II diabetic subjects with high fiber diets.

  • PDF

쌀눈기름의 급여가 KK 당뇨 마우스의 혈당 수준에 미치는 영향 (Supplementary effect of the rice germ oil on blood glucose in Diabetic KK Mice)

  • 이성현;박홍주;전혜경;이승교;이연숙
    • 한국지역사회생활과학회지
    • /
    • 제14권3호
    • /
    • pp.67-73
    • /
    • 2003
  • This study was carried out to investigate the supplementary effects of the rice germ oil compared with soy bean oil on blood glucose level of non-insulin dependent diabetic mice. Forty diabetic KK mice were fed two kinds of experimental diets with 20% lipid from soy bean oil as a control(CO) and rice germ oil(RG) for 8 weeks, respectively. Diet intake, body weight, organs weights and lipids levels of serum, liver and feces were measured. There was no significant difference in food and water intake, body weight gain and organs weights between experimental groups. The concentrations of fasting and random blood glucose were similar between CO and RG groups. There was no significant difference in blood glucose levels after glucose treatment during the glucose tolerance test between two groups. The levels of $HbA_{1c}$ as the index of blood glucose status, and insulin were similar in two groups. These results suggested that rice germ oil can't reduce blood glucose concentration of non-insulin dependent diabetic mice compared with soybean oil. But we need to investigate the hypoglycemic effect of rice germ oil by changing supplementary level and period.

  • PDF

Nano powder propolis 투여가 streptozotocin으로 유발된 당뇨병 rat의 혈당에 미치는 영향 (Hypoglycemic effects of nano powder propolis on streptozotocin-induced diabetic rats)

  • 정년기;조영채;하창수;김희성
    • 한국동물위생학회지
    • /
    • 제33권2호
    • /
    • pp.199-206
    • /
    • 2010
  • To evaluate the hypoglycemic effect of nano powder propolis, streptozotocin (STZ) induced diabetic rats were divided into 2 groups : diabetic control group and nano powder propolis (0.9ml) group. Then the rats were fed with nano-powder-propolis for 4 weeks. After 4 weeks, oral glucose tolerance test (oral GTT) was performed and blood sugar levels after 16 hours fasting, body weights, and blood lipid levels were measured. Finally, pancreas were collected and examined by histopathology and immunohistochemistry. In conclusion, the nano-powder-propolis was effective in the treatment of diabetes due to the reduction of blood sugar level and the regeneration of damaged ${\beta}$-cells observed in streptozotocin-induced diabetic rats.

공복 혈당장애 및 내당능장애자에서 홍국의 섭취가 혈중지질 및 혈당 조절에 미치는 영향 (The Effect of Red-Yeast-Rice Supplement on Serum Lipid Profile and Glucose Control in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance)

  • 강미란;김지영;현예정;김혜진;여현양;송영득;이종호
    • Journal of Nutrition and Health
    • /
    • 제41권1호
    • /
    • pp.31-40
    • /
    • 2008
  • 내당능 장애와 공복혈당장애는 장차 당뇨병으로 진행되거나 심혈관 질환을 일으키는 위험인자로 간주되어 적절한 혈당 및 혈중지질수치의 조절이 필요하다. 홍국의 기능성분인 모나콜린-K는 stalin계열 약물의 주원료로서 이미 지질 강하제로 잘 알려져 있다. 홍국의 지질 강하제 이외의 다른 효과로서 동물 자체 효력 시험과 문헌 고찰을 통해 혈당 강하 효과가 보고되고 있으므로 이중 맹검, 무작위배정, 위약 대조 인체시험을 통하여 홍국의 혈중 지질 및 혈당 개선에 대한 효능을 확인하는 목적으로 본 연구를 실시하였다. $18{\sim}80$세 사이의 남녀를 대상으로, 스크리닝 시 공복혈당이 110 mg/dl이상 126 mg/dl 이하인 공복 혈당 장애이거나 경구 당 부하 검사 2시간 후 혈당이 140 mg/dl 이상 199 mg/dl 이하인 내당능 장애자이거나 당화혈색소 수치가 6% 이상 7% 이하인 자로서 심각한 합병증이 없는 사람을 대상으로 하였으며, 홍국 저용량군 21명, 고용량군 23명, 위약군 20명으로 총 64명을 대상으로 12주간 검사에 대한 결과분석을 실시하였다. 1차 유효성 지표로 혈중 지질관련 지표인 중성지방, 총 콜레스테롤, LDL 콜레스테롤, HDL 콜레스테롤, Atherogenic index (AI)를 측정하였으며, 2차 유효성 지표로 혈당 지표인 공복 혈당, 경구 당부하 검사 2시간 혈당치, 당화혈색소, 인슐린, MOHAIR, 유리지방산을 측정하였다. 시험군에서 홍국제제 섭취 전후로 중성지방, 총 콜레스테롤, LDL 콜레스테롤, HDL콜레스테롤 수치가 유의적으로 개선되었으며 동맥경화지수도 유의적으로 향상되었다. 홍국 고용량군의 총 콜레스테롤, HDL 콜레스테롤과 LDL 콜레스테롤 및 동맥경화지수 개선 정도는 위약군의 변화량과 비교하여 유의적으로 개선되는 것으로 나타났고, 저용량군의 경우에도 LDL 콜레스테롤과 동맥경화지수 개선 정도가 위약군의 변화량과 비교하여 유의적으로 개선되었다. 홍국의 섭취가 혈당조절에 미치는 영향은 모든 시험군에서 제제 섭취 12주 후 공복혈당이 감소하였고, 시험군이 위약군에 비해 더욱 감소하였으나 통계적으로는 유의하지 않았다. 주평가지표인 공복혈당을 기준으로 공복혈당 110mg/dl 이상인 피험자만을 대상으로 당대사 관련 지표를 분석한 결과, 홍국 고용량군에서 공복혈당의 감소경향이 관찰되었고, 홍국 저용량군에서는 당화혈색소의 유의적인 감소효과를 확인하였으나 위약군의 변화량과 비교하여 유의적이지 않았다. 공복혈당 장애자 또는 내당능 장애자에서 하루 홍국 분말 2.52 g (저용량군) 또는 5.04 g (고용량군)을 포함한 건강기능식품을 12주간 섭취시킨 결과 혈중 지질 농도와 동맥경화 지수의 개선으로 심혈관 질환의 위험도를 낮출 수 있을 것으로 보이며, 고용량군일 경우 더 효과적일 것으로 사료된다.

Responses to Starch Infusion on Milk Synthesis in Low Yield Lactating Dairy Cows

  • Zou, Yang;Yang, Zhanshan;Guo, Yongqing;Li, Shengli;Cao, Zhijun
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제28권9호
    • /
    • pp.1266-1273
    • /
    • 2015
  • The effect of starch infusion on production, metabolic parameters and relative mRNA abundance was investigated in low yield lactating cows from 86 days in milk. Six Holstein cows fitted with permanent ruminal cannulas were arranged into one of two complete $3{\times}3$ Latin squares and infused with a starch solution containing 800 grams starch for 16 days. The three treatments were: i) ruminal and abomasal infusion with water (Control); ii) ruminal infusion with cornstarch solution and abomasal infusion with water (Rumen); iii) ruminal infusion with water and abomasal infusion with cornstarch solution (Abomasum). There were no significant differences (p>0.05) among the three treatments with low yield lactating cows in feed and energy intake, milk yield and composition, plasma metabolism, or even on gene expression. However, cows receiving starch through rumen performed better than directly through the abomasum during the glucose tolerance test procedure with a higher area under the curve (AUC; p = 0.08) and shorter half-time ($t^{1/2}$; p = 0.11) of plasma insulin, therefore, it increased glucose disposal, which stated a lipid anabolism other than mobilization after energy supplementation. In conclusion, extra starch infusion at concentration of 800 g/d did not enhance energy supplies to the mammary gland and improve the lactating performance in low yield lactating cows.

Efficacy and safety of Panax ginseng berry extract on glycemic control: A 12-wk randomized, double-blind, and placebo-controlled clinical trial

  • Choi, Han Seok;Kim, Sunmi;Kim, Min Jung;Kim, Myung-Sunny;Kim, Juewon;Park, Chan-Woong;Seo, Daebang;Shin, Song Seok;Oh, Sang Woo
    • Journal of Ginseng Research
    • /
    • 제42권1호
    • /
    • pp.90-97
    • /
    • 2018
  • Background: Antihyperglycemic effects of Panax ginseng berry have never been explored in humans. The aims of this study were to assess the efficacy and safety of a 12-wk treatment with ginseng berry extract in participants with a fasting glucose level between 100 mg/dL and 140 mg/dL. Methods: This study was a 12-wk, randomized, double-blind, placebo-controlled clinical trial. A total of 72 participants were randomly allocated to two groups of either ginseng berry extract or placebo, and 63 participants completed the study. The parameters related to glucose metabolism were assessed. Results: Although the present study failed to show significant antihyperglycemic effects of ginseng berry extract on the parameters related to blood glucose and lipid metabolism in the total study population, it demonstrated that ginseng berry extract could significantly decrease serum concentration of fasting glucose by 3.7% (p = 0.035), postprandial glucose at 60 min during 75 g oral glucose tolerance test by 10.7% (p = 0.006), and the area under the curve for glucose by 7.7% (p = 0.024) in those with fasting glucose level of 110 mg/dL or higher, while the placebo group did not exhibit a statistically significant decrease. Safety profiles were not different between the two groups. Conclusion: The present study suggests that ginseng berry extract has the potential to improve glucose metabolism in human, especially in those with fasting glucose level of 110 mg/dL or higher. For a more meaningful benefit, further research in people with higher blood glucose levels is required.

탁주 주박의 섭취가 스트렙토조토신으로 당뇨를 유발시킨 흰쥐의 혈당수준에 미치는 효과 (Effects of Takju(Korean turbid rice wine) Lees on the Serum Glucose levels in Streptozotocin-induced Diabetic Rats)

  • 김순미;조우균
    • 한국식생활문화학회지
    • /
    • 제21권6호
    • /
    • pp.638-643
    • /
    • 2006
  • This study was performed to determine the effect of Takju(Korean turbid rice wine) lees on the serum glucose level in streptozotocin-induced diabetic rats. 24 Sprague-Dawley male rats were divided into three groups: normal control(NC), diabetic control(DC) and diabetic rats(DS) were fed on experimental diet and water ad libitum for 4 weeks. DS diet was containing 20% Takju lees. Body weight gain and food Efficiency Ratio(FER) were significantly lower in DC and DS than NC. DS tended to have higher weight, weight gain and FEF than DC nevertheless food intake. Therefore Takju lees could possibly complement casein as a protein source. Gastrointestianl transit time in DS significantly decreased than NC while not significantly than DC. Serum lipid profiles and AST. ALT and amylase were not significantly different between diabetic DC and DS. Blood glucose was measured at fasting state and 30, 60, 90 and 120 minute by oral glucose tolerance test, DS tended to lower the mean(${\pm}$ SE) incremental blood glucose concentrations than DC and was significantly low at 120 min. But incremental AUG(area under the curve) of postprandial glucose response was not significantly different. In conclusion, in spite of high contents of carbohydrate Takju lees perhaps have a benefit effect on the diabetes.

탄수화물의 급원과 식이섬유의 종류를 달리한 식이가 제 2형 당뇨 쥐의 당대사 및 지질대사에 미치는 영향 (Effect of Feeding with Different Source of Carbohydrate and Fiber on Carbohydrate and Lipid Metabolism in Type 2 Diabetic Rats)

  • 권상희;정혜진;심지애;손영애;김미경
    • 한국식생활문화학회지
    • /
    • 제22권1호
    • /
    • pp.157-165
    • /
    • 2007
  • This study was designed to evaluate the effects of fructose(F) or sucrose(S) and guar gum intake on carbohydrate and lipid metabolism in 15-week-old male Goto-Kakizaki(GK) rats. Fifty rats were randomly assigned to 5 groups which were different in carbohydrate(25% of carbohydrate) and fiber(5% w/w) sources. The carbohydrate(CHO) sources of each group were comstarch(control group, 100% of CHO), fructose with cellulose(F), fructose with guar gum(FG), sucrose with cellulose(S), and sucrose with guar gum(SG). Each group was fed exterimental diet for 4 weeks. We measured food intake, body weight gain, adipose tissues weight and organs weight. We conducted oral glucose tolerance test(OGTT) and measured plasma insulin concentration to examine carbohydrate metabolism. To evaluate lipid metabolism, we measured the lipid profile of plasma, liver and feces. Food intake and weight gain of FG or SG groups tended to be less than those of F or S groups. Perirenal and epididymal fat pad weights of SG group were significantly lower than those of S group and those of FG group tended to be lower than those of F group. In OGTT, blood glucose values of F or S groups were significantly higher than those of C group, and FG or SG groups tended to be lower than those of F or S groups during the experimental time. The area under the curve(AUC) of C group was significantly highest among the groups, AUC and plasma insulin concentration of FG or SG groups tended to be lower than those of F or S groups. Plasma and hepatic triglyceride (TG) of FG and SG groups were significantly lower than those of F and S groups, plasma and hepatic total lipid(TL) and total cholesterol(TC) of FG and SG groups tended to be lower than those of F and S groups. Fecal TL, TG and TC of FG or SG groups tended to be higher than those of F and S groups. In conclusion, intake of guar gum should improve carbohydrate and lipid metabolism in partial substitution of fructose or sucrose for cornstarch in GK rats.

The Hypoglycemic Effects of Acarviosine-Glucose Modulate Hepatic and Intestinal Glucose Transporters In vivo

  • Chung, Mi-Ja;Lee, Young-Soo;Kim, Byoung-Chul;Lee, Soo-Bok;Moon, Tae-Hwa;Lee, Sung-Joon;Park, Kwan-Hwa
    • Food Science and Biotechnology
    • /
    • 제15권6호
    • /
    • pp.851-855
    • /
    • 2006
  • Acarviosine-glucose (AcvGlc) is an ${\alpha}$-glucosidase inhibitor and has similar inhibitory activity to acarbose in vitro. We synthesized AcvGlc by treating acarbose with Bacillus stearothermophilus maltogenic amylase and fed C57BL/6J and db/db mice with diets containing purified AcvGlc and acarbose for 1 week. AcvGlc (50 and 100 mg/100 g diet) significantly reduced plasma glucose and triglyceride levels in db/db mice by 42 and 51 %, respectively (p<0.0001). The hypoglycemic and hypotriglyceridemic effects of AcvGlc were slightly, but significantly, greater than those seen with acarbose treatment (p<0.0001) in C57BL/6J mice. In an oral glucose tolerance test, glucose tolerance was significantly improved at all time points (p<0.01). The expression of two novel glucose transporters (GLUTs), GLUT10 and GLUT12, were examined by Western blot analysis. GLUT10 was markedly increased in the db/db livers. After AcvGlc treatment, the expression of hepatic GLUT10 was decreased whereas intestinal GLUT12 was significantly increased in both strains of mice. Our results show that AcvGlc improves plasma lipid and glucose metabolism slightly more than acarbose. Regulation of hepatic GLUT10 and intestinal GLUT12 may be important in controlling blood glucose levels.

Hypoglycemic activity of diospyros peregrina fruits in diabetic rats

  • Dewanjee, Saikat;Maiti, Anup;Kundu, Mintu;Mandal, Subhash C
    • Advances in Traditional Medicine
    • /
    • 제8권3호
    • /
    • pp.279-285
    • /
    • 2008
  • Diospyros peregrina Gurke. (Ebenaceae) is a small middle sized tree grows luxuriantly in the plains of costal West Bengal, India. The objective of the study was to explore the antidiabetic activity of methanol extract of matured fruits of Diospyros peregrina to substantiate the folklore claim of traditional practitioners. It was also aimed to establish correlation with reduction of oxidative state associated with diabetes. Methanol extract of matured fruits of Diospyros peregrina was administered orally at doses of 150 and 300 mg/kg body weight for 12 consecutive days to normal and streptozotocin induced diabetic rats. Fasting blood glucose level was estimated in both normal and diabetic rats while serum lipid profiles, liver glycogen level and pancreatic thiobarbituric acid reactive substances (TBARS) were evaluated for diabetic rats. Initial and final changes in body weight were also recorded. Oral glucose tolerance test was performed during the course of study. Experimental findings showed significant antidiabetic potential of extract in term of reduction of fasting blood glucose level of both normal and diabetic rats. It was found that extract at the dose of 300 mg/kg body weight is more effective and percentage reduction (55.64) of elevated blood glucose level is comparable to that of standard drug glibenclamide (60.60) at a dose of 10 mg/kg body weight. Observed data found statistically significant in reduction of serum lipid and pancreatic TBARS levels whilst improvement was observed in liver glycogen level and body weight profiles in extract treated diabetic rats.